Johnson & Johnson shares fell Monday, extending the stock's plunge on the back of a Reuters investigation into the company's baby powder. The healthcare company was aware for decades that its baby powder contained traces of asbestos, according to Reuters, citing internal documents. Johnson & Johnson has denied the report. The majority of Wall Street analysts viewed the stock's initial decline as an overreaction, but acknowledged headwinds could arise from investors' concerns about the...
READ FULL ARTICLE »
Become a member to take advantage of more features, like commenting and voting.
Register or sign in today!